China Universal Asset Management Co., Ltd. Crispr Therapeutics Ag Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,205 shares of CRSP stock, worth $665,317. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,205
Previous 18,098
4.93%
Holding current value
$665,317
Previous $712,000
17.84%
% of portfolio
0.06%
Previous 0.07%
Shares
17 transactions
Others Institutions Holding CRSP
# of Institutions
484Shares Held
63.9MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$347 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$338 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$147 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$107 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$106 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.02B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....